Collectively, our evidence supports the hypothesis that RSV NS1 interferes with the antiviral signaling pathway by binding to the mitochondrial protein MAVS during early infection and disrupting the MAVS/RIG-I interaction that is necessary for signaling. This evidence concerns the gene RIGI and infection.